BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26063487)

  • 1. Improved genetic counseling in Alport syndrome by new variants of COL4A5 gene.
    Fernandez-Rosado F; Campos A; Alvarez-Cubero MJ; Ruiz A; Entrala-Bernal C
    Nephrology (Carlton); 2015 Jul; 20(7):502-5. PubMed ID: 26063487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal diagnosis and genetic counseling of X-linked Alport syndrome in China].
    Zhang HW; Ding J; Wang F; Yang HX
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):484-9. PubMed ID: 17953801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alport syndrome COL4A5 variant database.
    Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
    Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
    Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
    CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
    Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.
    Helle OMB; Pedersen TH; Ousager LB; Thomassen M; Hertz JM
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1452. PubMed ID: 32812400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A COL4A5 Missense Variant in a Han-Chinese Family with X-linked Alport Syndrome.
    Wu Y; Guo Y; Yuan J; Xu H; Chen Y; Zhang H; Yuan M; Deng H; Yuan L
    Curr Mol Med; 2019; 19(10):758-765. PubMed ID: 31490752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
    Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
    Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of a novel variant of COL4A5 gene in a pedigree affected with Alport syndrome].
    Liu X; Gao M; Zou Y; Wang L; Kang R; Xu P; Niu Y; Huang S; Li J; Xie H; Gao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Aug; 37(8):807-810. PubMed ID: 32761583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage analysis and a novel COL4A5 mutation in a large Turkish family with Alport syndrome.
    Tug E; Percin FE; Pala E; Baysoy G
    Genet Couns; 2011; 22(2):143-53. PubMed ID: 21848006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
    Tazón-Vega B; Ars E; Burset M; Santín S; Ruíz P; Fernández-Llama P; Ballarín J; Torra R
    Am J Kidney Dis; 2007 Aug; 50(2):257.e1-14. PubMed ID: 17660027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic and clinical analysis of a pedigree affected with X-linked dominant Alport syndrome due to a novel variant of COL4A5 gene].
    Ma Q; Wu J; Che L; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 May; 38(5):461-464. PubMed ID: 33974256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Linked Glomerulopathy Due to COL4A5 Founder Variant.
    Barua M; John R; Stella L; Li W; Roslin NM; Sharif B; Hack S; Lajoie-Starkell G; Schwaderer AL; Becknell B; Wuttke M; Köttgen A; Cattran D; Paterson AD; Pei Y
    Am J Kidney Dis; 2018 Mar; 71(3):441-445. PubMed ID: 29198386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
    Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
    Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
    Wang F; Wang Y; Ding J; Yang J
    Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of a novel mutation in COL4A5 gene from a Chinese family with X-linked alport syndrome].
    Peng CL; Liang H; Z ou QL; Wang J; Liu CS; Zhang XF; Chen J; Hu SN
    Yi Chuan Xue Bao; 2004 Nov; 31(11):1190-5. PubMed ID: 15651669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.